Former Cerebral vice president Matthew Truebe says the $4.8 billion company “consistently and at times egregiously put profits and growth before patient safety.”
Former Cerebral vice president Matthew Truebe says the $4.8 billion company “consistently and at times egregiously put profits and growth before patient safety.”